Biotech / Medtech Archives | citybizSciencenews

Novavax Raises 2026 Revenue Outlook After Q2 Earnings Beat

Thursday, August 6, 2026Win WarfieldView original

Novavax Inc. (NASDAQ: NVAX) raised its 2026 revenue guidance after reporting second-quarter results that topped Wall Street expectations, sending shares higher... Read More

The post Novavax Raises 2026 Revenue Outlook After Q2 Earnings Beat appeared first on citybiz.